Published in Drug Law Weekly, September 30th, 2008
"As a leading innovator in stem cell engineering, we are pleased to strengthen our intellectual property position with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.